Tower Research Capital (TRC)’s Trevi Therapeutics TRVI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$37.8K	Sell	3,169 -7,292	-70%	-$81.6K	﹤0.01%	2985
2025 Q4	$131K	Buy	10,461 +7,675	+275%	+$88.7K	﹤0.01%	1759
2025 Q3	$25.5K	Sell	2,786 -4,412	-61%	-$33.1K	﹤0.01%	3086
2025 Q2	$39.4K	Buy	7,198 +4,884	+211%	+$30.4K	﹤0.01%	3180
2025 Q1	$14.6K	Sell	2,314 -338	-13%	-$1.61K	﹤0.01%	3286
2024 Q4	$10.9K	Sell	2,652 -1,251	-32%	-$4K	﹤0.01%	3762
2024 Q3	$13K	Sell	3,903 -3,158	-45%	-$9.39K	﹤0.01%	3545
2024 Q2	$21K	Buy	7,061 +6,451	+1,058%	+$17.9K	﹤0.01%	3737
2024 Q1	$2.1K	Sell	610 -6,947	-92%	-$15.5K	﹤0.01%	5118
2023 Q4	$10.1K	Buy	7,557 +1,104	+17%	+$1.67K	﹤0.01%	4290
2023 Q3	$14.1K	Buy	6,453 +4,951	+330%	+$11.2K	﹤0.01%	3717
2023 Q2	$3.59K	Buy	+1,502	New	+$3.79K	﹤0.01%	5048
2022 Q4	–	Sell	-9,786	Closed	-$15K	–	6381
2022 Q3	$15K	Buy	9,786 +5,912	+153%	+$19.4K	﹤0.01%	4180
2022 Q2	$11K	Sell	3,874 -5,603	-59%	-$13.8K	﹤0.01%	4392
2022 Q1	$21K	Buy	9,477 +1,160	+14%	+$1.2K	﹤0.01%	3499
2021 Q4	$7K	Buy	8,317 +3,514	+73%	+$3.69K	﹤0.01%	4951
2021 Q3	$7K	Buy	4,803 +616	+15%	+$1.09K	﹤0.01%	4676
2021 Q2	$10K	Buy	4,187 +2,950	+238%	+$6.64K	﹤0.01%	4403
2021 Q1	$3K	Sell	1,237 -3,991	-76%	-$11.7K	﹤0.01%	4928
2020 Q4	$13K	Buy	5,228 +3,821	+272%	+$12.4K	﹤0.01%	4165
2020 Q3	$6K	Buy	+1,407	New	+$6.61K	﹤0.01%	4313
2019 Q4	–	Sell	-2,344	Closed	-$11K	–	4366
2019 Q3	$11K	Buy	2,344 +1,142	+95%	+$6.21K	﹤0.01%	2888
2019 Q2	$9K	Buy	+1,202	New	+$10.4K	﹤0.01%	2632